LIN ELIZABETH YEU sold 4.7% of their position (1.14K shares) of TARSUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $78.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/19/2026ACC: 0001842190-26-000007
Director
Since Dec 2021
-1.14K
Net shares
Net seller
$78.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.14K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−375.00
Price / share
$69.42
Trade value
$26.03K
% of position
1.5%
3/17/2026
24.45K→24.08K
Common Stock
Direct
Shares
−379.00
Price / share
$68.71
Trade value
$26.04K
% of position
1.6%
3/18/2026
24.08K→23.70K
Common Stock
Direct
Shares
−390.00
Price / share
$67.00
Trade value
$26.13K
% of position
1.6%
3/19/2026
23.70K→23.31K
Total
Net shares
−1.14K
Net value
-$78.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −375.00 | $69.42 | $26.03K | 1.5% | 24.45K | 24.08K |
| Common Stock Direct | 3/18/2026 | S · Sale | −379.00 | $68.71 | $26.04K | 1.6% | 24.08K | 23.70K |
| Common Stock Direct | 3/19/2026 | S · Sale | −390.00 | $67.00 | $26.13K | 1.6% | 23.70K | 23.31K |
| Total | −1.14K | -$78.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned12.04K
Common Stock
IndirectShares owned6.36K
Total
18.40K indirect18.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 12.04K | Indirect |
| Common Stock | 6.36K | Indirect |
| Total | 18.40K | 18.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported